Literature DB >> 28484119

Relationship Between Glucose Fluctuations and ST-Segment Resolution in Patients With ST-Elevation Acute Myocardial Infarction.

Keiichi Tsuchida1, Norihito Nakamura1, Satoshi Soda2, Ryohei Sakai1, Kota Nishida1, Jiro Hiroki1, Asami Kashiwa1, Yuki Fujihara1, Shinpei Kimura1, Yukio Hosaka1, Kazuyoshi Takahashi1, Hirotaka Oda1.   

Abstract

This study was conducted to assess whether any relationships exist between glucose fluctuations and electrocardiographic surrogate markers of reperfusion injury in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).We prospectively studied 63 consecutive patients with STEMI undergoing primary PCI. Patients had either diabetes (n = 30), impaired glucose tolerance (n = 26), impaired fasting glucose (n = 1), or normal glucose tolerance (n = 6). STsegment resolution (STR, %) was measured using electrocardiograms recorded 60 minutes after PCI. STR was categorized as ≥ 30% and < 30%. Glucose fluctuations were assessed by the following parameters obtained from a continuous glucose monitoring system: mean amplitude of glucose excursion (MAGE, mg/dL); and area under curve with reference to mean blood glucose (AUCMBG, mg/ dL/day).Both MAGE and AUCMBG were significantly higher in STR < 30%. In univariate analysis, MAGE ≥ 70 mg/dL (OR = 17.0; 95%CI, 1.93-150.12; P < 0.01), AUCMBG ≥ 20 mg/dL/day (OR = 10.9; 95%CI, 1.92-61.77; P < 0.01), and reperfusion arrhythmias (OR = 7.6; 95%CI, 1.32-44.29; P < 0.05) were significantly associated with suboptimal STR. Multiple logistic regression analysis showed only MAGE ≥ 70 mg/dL was predictive of suboptimal STR (OR = 22.5; 95%CI, 2.43-208.66, P < 0.01).Parameters of glucose fluctuations correlated with electrocardiographic surrogate markers of impaired myocardial salvage in STEMI after reperfusion therapy. Our results suggest that glucose fluctuations may represent a potential therapeutic target to reduce myocardial reperfusion injury in STEMI.

Entities:  

Keywords:  Reperfusion injury; STEMI

Mesh:

Substances:

Year:  2017        PMID: 28484119     DOI: 10.1536/ihj.16-250

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  3 in total

1.  Glycemic variability is associated with myocardial damage in nondiabetic patients with ST-elevation myocardial infarction.

Authors:  Satoshi Oka; Juntaro Deyama; Ken Umetani; Tomoko Harama; Takuya Shimizu; Aritaka Makino; Keita Sano; Masahiko Nakamura
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-05-16

2.  Intervention by clinical pharmacists can improve blood glucose fluctuation in patients with diabetes and acute myocardial infarction: A propensity score-matched analysis.

Authors:  Fang-Hong Shi; Long Shen; Jiang Yue; Jing Ma; Zhi-Chun Gu; Hao Li; Hou-Wen Lin
Journal:  Pharmacol Res Perspect       Date:  2021-04

3.  Impact of acute diabetes decompensation on outcomes of diabetic patients admitted with ST-elevation myocardial infarction.

Authors:  Mayada Issa; Fahad Alqahtani; Chalak Berzingi; Mohammad Al-Hajji; Tatiana Busu; Mohamad Alkhouli
Journal:  Diabetol Metab Syndr       Date:  2018-07-17       Impact factor: 3.320

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.